Jon Scott Jacobsen
Corporate Officer/Principal presso ACLARIS THERAPEUTICS, INC.
Posizioni attive di Jon Scott Jacobsen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Storia della carriera di Jon Scott Jacobsen
Precedenti posizioni note di Jon Scott Jacobsen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - | - |
Aclaris Life Sciences, Inc.
 Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Direttore Tecnico/Scientifico/R&S | 26/06/2014 | - |
| Corporate Officer/Principal | 01/01/2011 | - |
Formazione di Jon Scott Jacobsen
| Harvey Mudd College | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 3 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ACLARIS THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Aclaris Life Sciences, Inc.
Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Health Services |
- Borsa valori
- Insiders
- Jon Scott Jacobsen
- Esperienza
